Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development.

The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development. Leukemia. 2010 Jun; 24(6):1227-30.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.